Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2026-04-15 @ 3:32 AM
Study NCT ID:
NCT05905458
Status:
COMPLETED
Last Update Posted:
2024-12-03
First Post:
2023-06-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs)
Sponsor:
Chengdu Suncadia Medicine Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-28
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-22
Completion Date Type:
ACTUAL
First Submit Date:
2023-06-07
First Submit QC Date:
None
Study First Post Date:
2023-06-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-02
Last Update Post Date:
2024-12-03
Last Update Post Date Type:
ACTUAL